Detailed information for compound 816650

Basic information

Technical information
  • TDR Targets ID: 816650
  • Name: 4-(2,5-dioxopyrrolidin-1-yl)-N-(1,3-thiazol-2 -yl)benzamide
  • MW: 301.32 | Formula: C14H11N3O3S
  • H donors: 1 H acceptors: 4 LogP: 0.9 Rotable bonds: 4
    Rule of 5 violations (Lipinski): 1
  • SMILES: O=C1CCC(=O)N1c1ccc(cc1)C(=O)Nc1nccs1
  • InChi: 1S/C14H11N3O3S/c18-11-5-6-12(19)17(11)10-3-1-9(2-4-10)13(20)16-14-15-7-8-21-14/h1-4,7-8H,5-6H2,(H,15,16,20)
  • InChiKey: WXECFKGEINUGKU-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 4-(2,5-dioxopyrrolidin-1-yl)-N-thiazol-2-yl-benzamide
  • 4-(2,5-dioxo-1-pyrrolidinyl)-N-(2-thiazolyl)benzamide
  • 4-succinimido-N-thiazol-2-yl-benzamide
  • 4-(2,5-Dioxo-pyrrolidin-1-yl)-N-thiazol-2-yl-benzamide
  • BAS 01170195
  • STOCK2S-42803
  • ZINC00188973
  • Oprea1_843954
  • Oprea1_077800
  • CBMicro_008928
  • BIM-0008766.P001

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Plasmodium vivax enoyl-acyl carrier protein reductase 0.0417 0.3894 1
Mycobacterium tuberculosis Probable 3-oxoacyl-[acyl-carrier protein] reductase FabG2 (3-ketoacyl-acyl carrier protein reductase) 0.0028 0.0098 0.0251
Mycobacterium ulcerans 3-oxoacyl-ACP reductase 0.0028 0.0098 0.0251
Entamoeba histolytica 3-oxoacyl-(acyl-carrier protein) reductase, putative 0.0028 0.0098 0.5149
Plasmodium falciparum enoyl-acyl carrier reductase 0.0417 0.3894 1
Schistosoma mansoni 3-oxoacyl-[ACP] reductase 0.0028 0.0098 0.5149
Mycobacterium leprae NADH-DEPENDENT ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE INHA (NADH-DEPENDENT ENOYL-ACP REDUCTASE) 0.0417 0.3894 1
Loa Loa (eye worm) hypothetical protein 0.0036 0.0172 1
Loa Loa (eye worm) 3-hydroxyacyl-CoA dehydrogenase type II 0.0028 0.0098 0.5683
Mycobacterium ulcerans short-chain type dehydrogenase/reductase 0.0028 0.0098 0.0251
Mycobacterium ulcerans short chain dehydrogenase 0.0028 0.0098 0.0251
Mycobacterium ulcerans short chain dehydrogenase 0.0028 0.0098 0.0251
Mycobacterium ulcerans 20-beta-hydroxysteroid dehydrogenase FabG3 0.0028 0.0098 0.0251
Mycobacterium tuberculosis Possible 20-beta-hydroxysteroid dehydrogenase FabG3 (cortisone reductase) ((R)-20-hydroxysteroid dehydrogenase) 0.0028 0.0098 0.0251
Trypanosoma cruzi oxidoreductase-like protein, putative 0.0028 0.0098 0.5683
Mycobacterium ulcerans short chain dehydrogenase 0.0028 0.0098 0.0251
Mycobacterium ulcerans short-chain type dehydrogenase/reductase 0.0028 0.0098 0.0251
Trichomonas vaginalis hypothetical protein 0.0417 0.3894 1
Brugia malayi hypothetical protein 0.0038 0.019 0.019
Loa Loa (eye worm) retinol dehydrogenase 12 0.0028 0.0098 0.5683
Trypanosoma brucei ubiquitin carboxyl-terminal hydrolase, putative 0.0036 0.0172 1
Trichomonas vaginalis Clan CA, family C19, ubiquitin hydrolase-like cysteine peptidase 0.0036 0.0172 0.0442
Echinococcus granulosus ubiquitin carboxyl terminal hydrolase 8 0.0036 0.0172 0.906
Entamoeba histolytica hypothetical protein 0.0038 0.019 1
Mycobacterium ulcerans short chain dehydrogenase 0.0028 0.0098 0.0251
Treponema pallidum exodeoxyribonuclease (exoA) 0.0018 0 0.5
Echinococcus granulosus Basic leucine zipper bZIP transcription 0.0038 0.019 1
Mycobacterium ulcerans short-chain type dehydrogenase/reductase 0.0028 0.0098 0.0251
Mycobacterium tuberculosis Probable oxidoreductase 0.0028 0.0098 0.0251
Mycobacterium tuberculosis Probable short-chain type dehydrogenase/reductase 0.0028 0.0098 0.0251
Brugia malayi oxidoreductase, short chain dehydrogenase/reductase family protein 0.0028 0.0098 0.0098
Mycobacterium ulcerans short-chain type dehydrogenase/reductase 0.0028 0.0098 0.0251
Brugia malayi Ubiquitin carboxyl-terminal hydrolase family protein 0.0036 0.0172 0.0172
Mycobacterium ulcerans 3-ketoacyl-ACP reductase 0.0028 0.0098 0.0251
Plasmodium vivax 3-oxoacyl-[acyl-carrier-protein] reductase, putative 0.0028 0.0098 0.0251
Trypanosoma brucei beta-ketoacyl-ACP reductase 0.0028 0.0098 0.5683
Trichomonas vaginalis Clan CA, family C19, ubiquitin hydrolase-like cysteine peptidase 0.0036 0.0172 0.0442
Schistosoma mansoni ubiquitin-specific peptidase 2 (C19 family) 0.0036 0.0172 0.906
Brugia malayi oxidoreductase, short chain dehydrogenase/reductase family protein 0.0028 0.0098 0.0098
Mycobacterium tuberculosis Probable dehydrogenase/reductase 0.0028 0.0098 0.0251
Mycobacterium ulcerans short-chain type dehydrogenase/reductase 0.0028 0.0098 0.0251
Echinococcus multilocularis Peptidase C19, ubiquitin carboxyl terminal hydrolase 2 0.0036 0.0172 0.906
Chlamydia trachomatis enoyl-acyl-carrier protein reductase 0.0417 0.3894 1
Trypanosoma cruzi beta-ketoacyl-ACP reductase 0.0028 0.0098 0.5683
Mycobacterium ulcerans oxidoreductase 0.0028 0.0098 0.0251
Mycobacterium ulcerans short chain dehydrogenase 0.0028 0.0098 0.0251
Loa Loa (eye worm) oxidoreductase 0.0028 0.0098 0.5683
Mycobacterium ulcerans enoyl-(acyl carrier protein) reductase 0.0417 0.3894 1
Echinococcus granulosus ubiquitin specific protease 41 0.0036 0.0172 0.906
Plasmodium falciparum 3-oxoacyl-[acyl-carrier-protein] reductase 0.0028 0.0098 0.0251
Loa Loa (eye worm) hypothetical protein 0.0028 0.0098 0.5683
Giardia lamblia Ubiquitin carboxyl-terminal hydrolase 4 0.0036 0.0172 1
Mycobacterium tuberculosis Possible oxidoreductase 0.0028 0.0098 0.0251
Trichomonas vaginalis conserved hypothetical protein 0.0036 0.0172 0.0442
Leishmania major dehydrogenase/oxidoreductase-like protein 0.0028 0.0098 0.5683
Trypanosoma cruzi ubiquitin carboxyl-terminal hydrolase, putative 0.0036 0.0172 1
Leishmania major oxidoreductase-like protein 0.0028 0.0098 0.5683
Trypanosoma brucei oxidoreductase-like protein 0.0028 0.0098 0.5683
Echinococcus multilocularis ubiquitin carboxyl terminal hydrolase 8 0.0036 0.0172 0.906
Wolbachia endosymbiont of Brugia malayi enoyl-ACP reductase 0.0417 0.3894 1
Leishmania major 3-oxoacyl-ACP reductase, putative 0.0028 0.0098 0.5683
Leishmania major dehydrogenase/oxidoreductase-like protein 0.0028 0.0098 0.5683
Leishmania major pteridine reductase 1 0.0028 0.0098 0.5683
Mycobacterium ulcerans short-chain type dehydrogenase/reductase 0.0028 0.0098 0.0251
Toxoplasma gondii enoyl-acyl carrier reductase ENR 0.0417 0.3894 1
Schistosoma mansoni transcription factor LCR-F1 0.0038 0.019 1
Echinococcus multilocularis 3 oxoacyl acyl carrier protein reductase 0.0028 0.0098 0.5149
Echinococcus multilocularis Basic leucine zipper (bZIP) transcription 0.0038 0.019 1
Mycobacterium ulcerans 3-alpha-hydroxysteroid dehydrogenase 0.0028 0.0098 0.0251
Mycobacterium ulcerans 3-oxoacyl-ACP reductase 0.0028 0.0098 0.0251
Mycobacterium ulcerans 3-ketoacyl-ACP reductase 0.0028 0.0098 0.0251
Entamoeba histolytica hypothetical protein 0.0038 0.019 1
Mycobacterium ulcerans 3-ketoacyl-ACP reductase 0.0028 0.0098 0.0251
Mycobacterium ulcerans short chain dehydrogenase 0.0028 0.0098 0.0251
Mycobacterium ulcerans short chain dehydrogenase 0.0028 0.0098 0.0251
Onchocerca volvulus 0.0028 0.0098 0.5
Echinococcus multilocularis ubiquitin specific protease 41 0.0036 0.0172 0.906
Echinococcus granulosus 3 oxoacyl acyl carrier protein reductase 0.0028 0.0098 0.5149
Mycobacterium ulcerans short-chain type dehydrogenase/reductase 0.0028 0.0098 0.0251
Entamoeba histolytica hypothetical protein 0.0038 0.019 1
Leishmania major ubiquitin hydrolase, putative,cysteine peptidase, Clan CA, family C19, putative 0.0036 0.0172 1
Toxoplasma gondii 3-ketoacyl-(acyl-carrier-protein) reductase 0.0028 0.0098 0.0251
Mycobacterium ulcerans short chain dehydrogenase 0.0028 0.0098 0.0251
Onchocerca volvulus 0.0028 0.0098 0.5
Mycobacterium ulcerans short chain dehydrogenase 0.0028 0.0098 0.0251
Toxoplasma gondii 2,4-dienoyl CoA reductase 2, peroxisomal family protein 0.0028 0.0098 0.0251
Schistosoma mansoni ubiquitin-specific peptidase 8 (C19 family) 0.0036 0.0172 0.906
Schistosoma mansoni hypothetical protein 0.0038 0.019 1
Mycobacterium ulcerans short chain dehydrogenase 0.0028 0.0098 0.0251
Mycobacterium tuberculosis Possible oxidoreductase 0.0028 0.0098 0.0251
Toxoplasma gondii short chain dehydrogenase family protein, putative 0.0028 0.0098 0.0251
Echinococcus granulosus Peptidase C19 ubiquitin carboxyl terminal hydrolase 2 0.0036 0.0172 0.906
Wolbachia endosymbiont of Brugia malayi Short-chain alcohol dehydrogenase family enzyme 0.0028 0.0098 0.0251
Mycobacterium tuberculosis Probable short-chain type dehydrogenase/reductase 0.0028 0.0098 0.0251
Mycobacterium ulcerans short chain dehydrogenase 0.0028 0.0098 0.0251
Trypanosoma cruzi beta-ketoacyl-ACP reductase 0.0028 0.0098 0.5683
Mycobacterium tuberculosis NADH-dependent enoyl-[acyl-carrier-protein] reductase InhA (NADH-dependent enoyl-ACP reductase) 0.0417 0.3894 1
Mycobacterium ulcerans 3-ketoacyl-ACP reductase 0.0028 0.0098 0.0251
Mycobacterium tuberculosis Probable short-chain type dehydrogenase/reductase 0.0028 0.0098 0.0251
Mycobacterium ulcerans short chain dehydrogenase 0.0028 0.0098 0.0251
Schistosoma mansoni dihydropteridine reductase 0.0028 0.0098 0.5149
Entamoeba histolytica ubiquitin carboxyl-terminal hydrolase domain containing protein 0.0036 0.0172 0.906
Entamoeba histolytica hypothetical protein 0.0038 0.019 1
Trypanosoma brucei pteridine reductase 1 0.0028 0.0098 0.5683
Trypanosoma cruzi ubiquitin carboxyl-terminal hydrolase, putative 0.0036 0.0172 1
Mycobacterium ulcerans 3-ketoacyl-ACP reductase 0.0028 0.0098 0.0251
Mycobacterium ulcerans short-chain type dehydrogenase/reductase 0.0028 0.0098 0.0251

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.